CN Stock MarketDetailed Quotes

002422 Sichuan Kelun Pharmaceutical

Watchlist
  • 32.72
  • +0.53+1.65%
Market Closed Nov 29 15:00 CST
52.40BMarket Cap17.69P/E (TTM)

Sichuan Kelun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sichuan Kelun Pharmaceutical Q3 2024 Earnings Date

Currency：CNYOct 29, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
5.72B
4.96B
-761.66M
Miss Est.
+14.26%
+0.35%
-13.31%
EPS
0.46
0.42
-0.04
Miss Est.
+27.69%
--
-8.64%
Analyst Rating
Strong Buy

Nov 30, 2024

Sichuan Kelun Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.000B--
--2024/Q4-- / 5.817B--
Oct 29, 20242024/Q34.962B / 5.723B--
Aug 29, 20242024/Q25.608B / 5.650B--
Apr 25, 20242024/Q16.219B / 5.897B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 6.000B--
--2024/Q4-- / 5.817B--
Oct 29, 20242024/Q34.962B / 5.723B--
Aug 29, 20242024/Q25.608B / 5.650B--
Apr 25, 20242024/Q16.219B / 5.897B--

Unlock Free Earnings Estimates

Sichuan Kelun Pharmaceutical Earnings Reports

  • Colon Pharmaceuticals: Report for the third quarter of 2024

    Oct 29 00:00

  • Colon Pharmaceuticals: Semi-Annual Report 2024

    Aug 29 00:00

  • Colon Pharmaceuticals: 2024 Semi-Annual Report Summary

    Aug 29 00:00

  • Sichuan Kelun Pharmaceutical: 2024 Half-Year Performance Bulletin

    Aug 13 00:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Strong Buy

      94.74%

    • Buy

      5.26%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data